Start free

Phio Pharmaceuticals Corp. (PHIO) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 16, 2026.

Filings shown
16
Open-market buys
14
Open-market sells
0
Buys, 10b5-1 box not checked
14 of 14

Counts cover the 16 most recent Form 4 filings Tradune holds for PHIO (filed Jun 29 – Nov 16, 2026); the score below covers only the trailing 90 days (11 buys, 0 sells). SEC EDGAR Form 4 filings for PHIO last checked Nov 21, 2026, 09:00 UTC; the latest PHIO filing Tradune holds was filed Nov 16, 2026. This is not guaranteed to be the complete record — see PHIO's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 13 filings Tradune holds for PHIO filed Sep 15 – Nov 16, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
David H. DemingDirector 4 0 24,000 — +$19,889
Ronald Todd PlottDirector 3 0 28,300 — +$25,539
Robert J. BittermanChairman, Pres. & CEO 2 0 27,000 — +$22,558
Patricia A. BradfordDirector 2 0 18,500 — +$18,943

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

100/ 100

Purchase cluster incl. officer
4 distinct buyers11 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

PHIO appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 17, 2026
    4 insiders buying · $104,028 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at PHIO

Insiders reported 14 open-market purchases of PHIO between Jun 29, 2026 and Nov 16, 2026, across 4 distinct buyers. The most recent purchase was reported by David H. Deming (Director) on Nov 13, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

David H. Deming Director · filed Nov 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,000 $0.83 61,800 +5.1% Nov 13, 2026
Open-market purchase 10b5-1 box not checked 9,000 $0.81 58,800 +18% Nov 12, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

David H. Deming Director · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,200 $0.84 49,800 +12% Nov 11, 2026
Open-market purchase 10b5-1 box not checked 6,800 $0.84 44,600 +18% Nov 10, 2026
Ronald Todd Plott Director · filed Nov 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 18,300 $0.83 60,300 +44% Nov 9, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Nov 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 25,000 $0.82 789,871 +3.3% Nov 9, 2026
Ronald Todd Plott Director · filed Sep 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,000 $1.04 42,000 +14% Sep 29, 2026
Open-market purchase 10b5-1 box not checked 5,000 $1.03 37,000 +16% Sep 28, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Sep 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 400,000 — 764,871 +110% Sep 28, 2026
Ronald Todd Plott Director · filed Sep 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 17,000 — 32,000 +113% Sep 28, 2026
Lisa Cabott Carson Chief Financial Officer · filed Sep 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 108,000 — 189,112 +133% Sep 28, 2026
Patricia A. Bradford Director · filed Sep 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 6,500 $1.01 64,151 +11% Sep 24, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Sep 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000 $1.03 364,871 +0.6% Sep 22, 2026
Patricia A. Bradford Director · filed Sep 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 12,000 $1.03 57,651 +26% Sep 15, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 68,550 $1.03 362,871 −16% Sep 11, 2026
Lisa Cabott Carson Chief Financial Officer · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 12,888 $1.03 81,112 −14% Sep 11, 2026
Ronald Todd Plott Director · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 15,000 $1.14 15,000 — Aug 19, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Aug 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $1.06 431,421 +2.4% Aug 18, 2026
Robert J. Bitterman Chairman, Pres. & CEO · filed Jun 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $0.99 421,421 +2.4% Jun 26, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to PHIO's (Nov 16, 2026).

Frequently asked about PHIO insider activity

How many insiders bought PHIO stock in these Form 4 filings?

4 distinct insiders at Phio Pharmaceuticals Corp. reported 14 open-market purchases (Form 4 code P) of PHIO shares between Jun 29, 2026 and Nov 16, 2026, the most recent filed by David H. Deming (Director) on Nov 13, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for PHIO?

The most recent Form 4 on this page was filed by David H. Deming (Director) on Nov 16, 2026, reporting 2 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market PHIO insider purchase shown?

The largest open-market purchase among the filings shown was 25,000 PHIO shares at $0.82 (about $20,500) by Robert J. Bitterman (Chairman, Pres. & CEO) on Nov 9, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent PHIO insider purchases have the Form 4 10b5-1 box checked?

No. All 14 PHIO open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: David H. Deming (Director) on Nov 13, 2026, 3,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for PHIO — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.